FN2 Earnings Intelligence
Moderna, Inc. ratios (quarterly)
Moderna, Inc. (MRNA) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,623 | $1,279 | $1,132 | $1,908 | $1,723 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $108 | $142 | $1,016 | $389 | $145 | $895 | $667.8 |
| % Growth | - | - | - | - | - | -11.9% | - |
| Gross Profit | $18 | $23 | $809 | -$566 | $52 | - | - |
| % Margin | 16.7% | 16.2% | 79.6% | -145.5% | 35.9% | - | - |
| EBITDA | -$1,012 | -$851 | -$209 | -$1,332 | -$759 | - | - |
| % Margin | -937.0% | -599.3% | -20.6% | -342.4% | -523.4% | - | - |
| Net Income | -$971 | -$825 | -$200 | -$1,343 | -$782 | - | - |
| % Margin | -899.1% | -581.0% | -19.7% | -345.2% | -539.3% | - | - |
| Diluted EPS | -$2.52 | -$2.13 | -$0.51 | -$3.40 | -$1.97 | -$1.10 | -$1.69 |
| % Growth | - | - | - | - | - | -115.6% | - |
| Operating Cash Flow | -$1,037 | - | - | -$630 | - | - | - |
| CapEx | $117 | - | - | $62 | - | - | - |
| Free Cash Flow | -$1,154 | - | - | -$692 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $108 | $142 | $1,016 | $389 | $145 | $895 | $667.8 |
| Gross Profit | $18 | $23 | $809 | -$566 | $52 | - | - |
| EBITDA | -$1,012 | -$851 | -$209 | -$1,332 | -$759 | - | - |
| Net Income | -$971 | -$825 | -$200 | -$1,343 | -$782 | - | - |
| Diluted EPS | -$2.52 | -$2.13 | -$0.51 | -$3.40 | -$1.97 | -$1.10 | -$1.69 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,623 | $1,279 | $1,132 | $1,908 | $1,723 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | $590 | $591 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$1,037 | - | - | -$630 | - |
| Capital Expenditure | $117 | - | - | $62 | - |
| Free Cash Flow | -$1,154 | - | - | -$692 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 16.7% | 16.2% | 79.6% | -145.5% | 35.9% |
| EBITDA Margin | -937.0% | -599.3% | -20.6% | -342.4% | -523.4% |
| Net Margin | -899.1% | -581.0% | -19.7% | -345.2% | -539.3% |
| FCF Margin | -1,068.5% | - | - | -177.9% | - |
| Diluted EPS Growth | - | - | - | - | - |